Hippocampal infusions of MARCKS peptides impair memory of rats on the radial-arm maze

Brain Research

Volumn 1308, Issue , 2010, Pages 147-152

  Timofeeva, Olga A ^a   Eddins, Donnie ^a   Yakel, Jerrel L ^b   Blackshear, Perry J ^b   Levin, Edward D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Hippocampus; MARCKS Peptide; Memory

Indexed keywords

AMINO ACID; BUNGAROTOXIN RECEPTOR; MARCKS PROTEIN; MARCKS PROTEIN[151-175]; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; DOSE RESPONSE; DRUG EFFECT; DRUG INFUSION; DRUG INHIBITION; FEMALE; HIPPOCAMPUS; IN VITRO STUDY; MAZE TEST; MEMORY DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT; WORKING MEMORY;

ANALYSIS OF VARIANCE; ANIMALS; CATHETERS, INDWELLING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HIPPOCAMPUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAZE LEARNING; MEMBRANE PROTEINS; MEMORY, SHORT-TERM; NEURONS; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RETENTION (PSYCHOLOGY);

RATTUS;

EID: 71049194297     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.10.040     Document Type: Article

References (31)

1. Arbuzova A., Schmitz A.A., and Vergeres G. Cross-talk unfolded: MARCKS proteins. Biochem. J. 362 (2002) 1-12
2. Bettany J.H., and Levin E.D. Ventral hippocampal alpha 7 nicotinic receptor blockade and chronic nicotine effects on memory performance in the radial-arm maze. Pharmacol. Biochem. Behav. 70 (2001) 467-474
3. Blackshear P.J. The MARCKS family of cellular protein kinase C substrates. J. Biol. Chem. 268 (1993) 1501-1504
4. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., and Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
5. Di Angelantonio S., Giniatullin R., Costa V., Sokolova E., and Nistri A. Modulation of neuronal nicotinic receptor function by the neuropeptides CGRP and substance P on autonomic nerve cells. Br. J. Pharmacol. 139 (2003) 1061-1073
6. Eddins D., Klein R.C., Yakel J.L., and Levin E.D. Hippocampal infusions of apolipoprotein E peptides induce long-lasting cognitive impairment. Brain Res. Bull. 79 (2009) 111-115
7. Felix R., and Levin E.D. Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats. Neuroscience 81 (1997) 1009-1017
8. Gay E.A., Klein R.C., and Yakel J.L. Apolipoprotein E-derived peptides block alpha7 neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 316 (2006) 835-842
9. Gay E.A., Klein R.C., Melton M.A., Blackshear P.J., and Yakel J.L. Inhibition of native and recombinant nicotinic acetylcholine receptors by the myristoylated alanine-rich C kinase substrate peptide. J. Pharmacol. Exp. Ther. 327 (2008) 884-890
10. Hashimoto K., Ishima T., Fujita Y., Matsuo M., Kobashi T., Takahagi M., Tsukada H., and Iyo M. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha7 nicotinic receptor agonist SSR180711. Biol. Psychiatry 63 (2008) 92-97
11. Hussain R.J., Stumpo D.J., Blackshear P.J., Lenox R.H., Abel T., and McNamara R.K. Myristoylated alanine rich C kinase substrate (MARCKS) heterozygous mutant mice exhibit deficits in hippocampal mossy fiber-CA3 long-term potentiation. Hippocampus 16 (2006) 495-503
12. Kawai H., Zago W., and Berg D.K. Nicotinic alpha 7 receptor clusters on hippocampal GABAergic neurons: regulation by synaptic activity and neurotrophins. J. Neurosci. 22 (2002) 7903-7912
13. Klein R.C., and Yakel J.L. Inhibition of nicotinic acetylcholine receptors by apolipoprotein E-derived peptides in rat hippocampal slices. Neuroscience 127 (2004) 563-567
14. Lendvai B., and Vizi E.S. Nonsynaptic chemical transmission through nicotinic acetylcholine receptors. Physiol. Rev. 88 (2008) 333-349
15. Levin E.D., Bradley A., Addy N., and Sigurani N. Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory. Neuroscience 109 (2002) 757-765
16. Levin E.D., McClernon F.J., and Rezvani A.H. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl) 184 (2006) 523-539
17. Levin E.D., Petro A., Rezvani A.H., Pollard N., Christopher N.C., Strauss M., Avery J., Nicholson J., and Rose J.E. Nicotinic alpha7- or beta2-containing receptor knockout: effects on radial-arm maze learning and long-term nicotine consumption in mice. Behav. Brain Res. 196 (2009) 207-213
18. Lu D., Yang H., Lenox R.H., and Raizada M.K. Regulation of angiotensin II-induced neuromodulation by MARCKS in brain neurons. J. Cell Biol. 142 (1998) 217-227
19. McNamara R.K., and Lenox R.H. Comparative distribution of myristoylated alanine-rich C kinase substrate (MARCKS) and F1/GAP-43 gene expression in the adult rat brain. J. Comp. Neurol. 379 (1997) 48-71
20. McNamara R.K., and Lenox R.H. Acute restraint stress reduces protein kinase C gamma in the hippocampus of C57BL/6 but not DBA/2 mice. Neurosci. Lett. 368 (2004) 293-296
21. McNamara R.K., Hussain R.J., Simon E.J., Stumpo D.J., Blackshear P.J., Abel T., and Lenox R.H. Effect of myristoylated alanine-rich C kinase substrate (MARCKS) overexpression on hippocampus-dependent learning and hippocampal synaptic plasticity in MARCKS transgenic mice. Hippocampus 15 (2005) 675-683
22. Nott A., and Levin E.D. Dorsal hippocampal alpha7 and alpha4beta2 nicotinic receptors and memory. Brain Res. 1081 (2006) 72-78
23. Ouimet C.C., Wang J.K., Walaas S.I., Albert K.A., and Greengard P. Localization of the MARCKS (87 kDa) protein, a major specific substrate for protein kinase C, in rat brain. J. Neurosci. 10 (1990) 1683-1698
24. Pellegrino L.J., Pellegrino A.S., and Cushman A.J. A stereotaxic atlas of the rat brain (1979), Plenum Press, New York Vol.
25. Pichat P., Bergis O.E., Terranova J.P., Urani A., Duarte C., Santucci V., Gueudet C., Voltz C., Steinberg R., Stemmelin J., Oury-Donat F., Avenet P., Griebel G., and Scatton B. SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia. Neuropsychopharmacology 32 (2007) 17-34
26. Placzek A.N., Zhang T.A., and Dani J.A. Nicotinic mechanisms influencing synaptic plasticity in the hippocampus. Acta Pharmacol. Sin. 30 (2009) 752-760
27. Saunders A.M., Schmader K., Breitner J.C., Benson M.D., Brown W.T., Goldfarb L., Goldgaber D., Manwaring M.G., Szymanski M.H., McCown N., et al. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 342 (1993) 710-711
28. Thomsen M.S., Christensen D.Z., Hansen H.H., Redrobe J.P., and Mikkelsen J.D. alpha(7) Nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatment. Neuropharmacology 56 (2009) 1001-1009
29. Tribollet E., Bertrand D., Marguerat A., and Raggenbass M. Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain. Neuroscience 124 (2004) 405-420
30. Verghese G.M., Johnson J.D., Vasulka C., Haupt D.M., Stumpo D.J., and Blackshear P.J. Protein kinase C-mediated phosphorylation and calmodulin binding of recombinant myristoylated alanine-rich C kinase substrate (MARCKS) and MARCKS-related protein. J. Biol. Chem. 269 (1994) 9361-9367
31. Wada E., Wada K., Boulter J., Deneris E., Heinemann S., Patrick J., and Swanson L.W. Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J. Comp. Neurol. 284 (1989) 314-335